Clark GM - Search Results

1

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.

Elledge RM, Green S, Ciocca D, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, O'Sullivan J, Martino S, Osborne CK. Elledge RM, et al. Among authors: clark gm. Clin Cancer Res. 1998 Jan;4(1):7-12. Clin Cancer Res. 1998. PMID: 9516946

2

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Chang J, et al. Among authors: clark gm. Cancer. 2003 Feb 1;97(3):545-53. doi: 10.1002/cncr.11083. Cancer. 2003. PMID: 12548595 Free article.

3

Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.

Fuqua SA, Schiff R, Parra I, Moore JT, Mohsin SK, Osborne CK, Clark GM, Allred DC. Fuqua SA, et al. Among authors: clark gm. Cancer Res. 2003 May 15;63(10):2434-9. Cancer Res. 2003. PMID: 12750263 Free PMC article.

4

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.

Nguyen DM, Sam K, Tsimelzon A, Li X, Wong H, Mohsin S, Clark GM, Hilsenbeck SG, Elledge RM, Allred DC, O'Connell P, Chang JC. Nguyen DM, et al. Among authors: clark gm. Clin Cancer Res. 2006 Sep 1;12(17):5047-54. doi: 10.1158/1078-0432.CCR-05-2248. Clin Cancer Res. 2006. PMID: 16951220

5

Prognostic factors: rationale and methods of analysis and integration.

Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentiis M, Osborne CK. Clark GM, et al. Breast Cancer Res Treat. 1994;32(1):105-12. doi: 10.1007/BF00666211. Breast Cancer Res Treat. 1994. PMID: 7819579 Review.

6

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK. Elledge RM, et al. Among authors: clark gm. J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705. J Natl Cancer Inst. 1994. PMID: 7908990

7

The p53 tumor-suppressor gene in human breast cancer.

Allred DC, Elledge R, Clark GM, Fuqua SA. Allred DC, et al. Among authors: clark gm. Cancer Treat Res. 1994;71:63-77. doi: 10.1007/978-1-4615-2592-9_4. Cancer Treat Res. 1994. PMID: 7946959 Review. No abstract available.

8

p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.

Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC. Elledge RM, et al. Among authors: clark gm. Cancer Res. 1994 Jul 15;54(14):3752-7. Cancer Res. 1994. PMID: 8033095

9

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. Among authors: clark gm. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

10

Prognostic significance of p53 gene alterations in node-negative breast cancer.

Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC, McGuire WL. Elledge RM, et al. Among authors: clark gm. Breast Cancer Res Treat. 1993;26(3):225-35. doi: 10.1007/BF00665800. Breast Cancer Res Treat. 1993. PMID: 8251647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

767 results

Search Page

Filters